118 related articles for article (PubMed ID: 30711939)
1. Tumorous CD10 Is More Strongly Related to the Progression of Urothelial Carcinoma than Stromal CD10.
Kumagai-Togashi A; Uozaki H; Kikuchi Y; Watabe S; Numakura S; Watanabe M
Anticancer Res; 2019 Feb; 39(2):635-640. PubMed ID: 30711939
[TBL] [Abstract][Full Text] [Related]
2. Assessing CD 10 Expression Level and Its Prognostic Impact in Egyptian Patients with Urothelial Carcinoma.
Hussien MT; Helmy E; Elsaba TM; Elkady A; Alrefai H; Hetta HF
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1573-1583. PubMed ID: 32592351
[TBL] [Abstract][Full Text] [Related]
3. CD10 and E-cad expression in urinary bladder urothelial and squamous cell carcinoma.
Omran OM
J Environ Pathol Toxicol Oncol; 2012; 31(3):203-12. PubMed ID: 23339695
[TBL] [Abstract][Full Text] [Related]
4. Both cancerous miR-21 and stromal miR-21 in urothelial carcinoma are related to tumour progression.
Ohno R; Uozaki H; Kikuchi Y; Kumagai A; Aso T; Watanabe M; Watabe S; Muto S; Yamaguchi R
Histopathology; 2016 Dec; 69(6):993-999. PubMed ID: 27383043
[TBL] [Abstract][Full Text] [Related]
5. CD 10 expression intensity in various grades and stages of urothelial carcinoma of urinary bladder.
Atique M; Abbasi MS; Jamal S; Khadim MT; Akhtar F; Jamal N
J Coll Physicians Surg Pak; 2014 May; 24(5):351-5. PubMed ID: 24848395
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD10 in urothelial carcinoma of the bladder and its correlation with histopathological grade, pathological stage, and survival of patients.
Shukla SK; Chandra S; Chauhan N; Sarpal R
J Cancer Res Ther; 2021; 17(4):887-892. PubMed ID: 34528537
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of CD10 expression in clinical outcome of invasive breast carcinoma.
Vo TN; Mekata E; Umeda T; Abe H; Kawai Y; Mori T; Kubota Y; Shiomi H; Naka S; Shimizu T; Murata S; Yamamoto H; Ishida M; Tani T
Breast Cancer; 2015 Mar; 22(2):117-28. PubMed ID: 23575921
[TBL] [Abstract][Full Text] [Related]
8. High CD10 expression predicts favorable outcome in surgically treated lymph node-positive bladder cancer patients.
Seiler R; von Gunten M; Thalmann GN; Fleischmann A
Hum Pathol; 2012 Feb; 43(2):269-75. PubMed ID: 21835428
[TBL] [Abstract][Full Text] [Related]
9. CD10 expression in tumour and stromal cells of bladder carcinoma: an association with bilharziasis.
Abdou AG
APMIS; 2007 Nov; 115(11):1206-18. PubMed ID: 18092952
[TBL] [Abstract][Full Text] [Related]
10. CD10-positive stromal cells in gastric carcinoma: correlation with invasion and metastasis.
Huang WB; Zhou XJ; Chen JY; Zhang LH; Meng K; Ma HH; Lu ZF
Jpn J Clin Oncol; 2005 May; 35(5):245-50. PubMed ID: 15886270
[TBL] [Abstract][Full Text] [Related]
11. CD10-a new prognostic stromal marker in breast carcinoma, its utility, limitations and role in breast cancer pathogenesis.
Jana SH; Jha BM; Patel C; Jana D; Agarwal A
Indian J Pathol Microbiol; 2014; 57(4):530-6. PubMed ID: 25308002
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components.
Ioachim E; Michael MC; Salmas M; Damala K; Tsanou E; Michael MM; Malamou-Mitsi V; Stavropoulos NE
BMC Cancer; 2006 May; 6():140. PubMed ID: 16732887
[TBL] [Abstract][Full Text] [Related]
13. INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract.
Lee HY; Li CC; Huang CN; Li WM; Yeh HC; Ke HL; Yang KF; Liang PI; Li CF; Wu WJ
J Surg Oncol; 2015 Mar; 111(4):414-22. PubMed ID: 25488476
[TBL] [Abstract][Full Text] [Related]
14. Stromal CD10 expression in breast cancer correlates with tumor invasion and cancer stem cell phenotype.
Louhichi T; Saad H; Dhiab MB; Ziadi S; Trimeche M
BMC Cancer; 2018 Jan; 18(1):49. PubMed ID: 29306324
[TBL] [Abstract][Full Text] [Related]
15. CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo.
Lee KW; Sung CO; Kim JH; Kang M; Yoo HY; Kim HH; Um SH; Kim SH
Int J Cancer; 2015 Jan; 136(2):310-21. PubMed ID: 24895167
[TBL] [Abstract][Full Text] [Related]
16. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome.
Iwaya K; Ogawa H; Izumi M; Kuroda M; Mukai K
Virchows Arch; 2002 Jun; 440(6):589-93. PubMed ID: 12070597
[TBL] [Abstract][Full Text] [Related]
17. Protein expression and amplification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prognostic marker of patient survival.
Luo JH; Xie D; Liu MZ; Chen W; Liu YD; Wu GQ; Kung HF; Zeng YX; Guan XY
Int J Cancer; 2008 Jun; 122(11):2554-61. PubMed ID: 18246597
[TBL] [Abstract][Full Text] [Related]
18. Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma.
Liang PI; Wu LC; Sheu JJ; Wu TF; Shen KH; Wang YH; Wu WR; Shiue YL; Huang HY; Hsu HP; Chen YH; Chen LT; Li CF; Liao AC
J Clin Pathol; 2012 Sep; 65(9):802-7. PubMed ID: 22685262
[TBL] [Abstract][Full Text] [Related]
19. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
Liang PI; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Wu JY; Li CF
J Clin Pathol; 2013 Jul; 66(7):573-82. PubMed ID: 23539739
[TBL] [Abstract][Full Text] [Related]
20. Significance of stromal reaction patterns in invasive urothelial carcinoma.
Samaratunga H; Fairweather P; Purdie D
Am J Clin Pathol; 2005 Jun; 123(6):851-7. PubMed ID: 15899775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
